Quotes

Back To Menu

Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Large Cap

Invest

12 Dec 2018 | 03:59 PM

1,386.80
16.40 (1.20%)

  • Outperforms Index

    13.53%

    Return (1Y)

    Beaten S&P BSE Healthcare by 16.48%

  • More Volatile

    1.72%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.58%

  • Consistent Performer

    7/12

    Months

    beaten S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,812

1,812.00

1,020

1,020.00

News & Announcements

  • Glaxosmithkline Pharmaceuticals standalone net profit declines 22.67% in the September 2018 quarter

    51 days ago

  • GlaxoSmithKline Pharmaceuticals announces board meeting date

    74 days ago

  • Glaxosmithkline Pharmaceuticals fixes record date for bonus issue

    110 days ago

  • Glaxosmithkline Pharmaceuticals standalone net profit rises 235.31% in the June 2018 quarter

    140 days ago

Price vs Volume

Stock Trivia

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -8.51% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -17.4% since past 1 Year

  • MF shareholding in Glaxosmithkline Pharma Ltd has increased by 35.47% since past 1 Year

  • Glaxosmithkline Pharma Ltd has the 3rd highest P/Bratio according to FY201803 data among stocks in Pharmaceuticals Sector

Loading...

Peer Comparison on Risk - Return

Loading...
Loading...